Niacin 100 mg
60/100
Review before taking
- Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)
The safety score is low because the 100mg dose of niacin is nearly three times the recommended maximum daily limit of 35mg.
Label Data
1 Tablet(s)
Serving Size
90
Servings
Vitamin
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
100 mg NE
(625% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 2.9× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
Other Ingredients
Microcrystalline Cellulose
Di-Calcium Phosphate
Stearic Acid
Rice Bran
Cellulose
Magnesium Stearate
Pharmaceutical Glaze
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Vegetarian
Adult (18 - 50 Years)
No Allergies
Gluten Free
Product Information
📋 Directions for Use
Directions: One tablet daily.
⚠️ Warnings & Precautions
Warning: In certain individuals, niacin may produce flushing which, under normal use, will disappear. If condition persists, however, consult a physician.
Keep out of reach of children.
🧪 Formulation Notes
Free from artificial colors and artificial preservatives. Free from all of the major allergens identified in the U.S. Food Allergen Labeling and Consumer Protection Act.
Vegetarian
Gluten free
Heart support
Additional Information
Keep tightly closed in a cool, dry place.
Product Details
UPC / SKU
0 97467 01850 1
DSLD Entry Date
2023-12-14
Product Type
Vitamin
Form
Tablet or Pill
Brand
NaturesPlus
DSLD ID
298564
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100